Brief: Harrow Acquires Santen’s Branded Ophthalmic Portfolio
18/07/2023 22:01
July 18 (Reuters) - Harrow Health Inc HROW.O :
* HARROW ACQUIRES SANTEN’S BRANDED OPHTHALMIC PORTFOLIO
* HARROW HEALTH INC - EXPECTS TRANSACTION TO REDUCE
COMPANY'S
AGGREGATE LEVERAGE RATIO OF ADJUSTED EBITDA TO DEBT
* HARROW HEALTH- FINANCING FOR DEAL PROVIDED THROUGH
EXPANSION OF
HARROW'S SECURED CREDIT FACILITY
Source text for Eikon: ID:nBw89mFRka
Further company coverage: HROW.O
(Reuters.Briefs@thomsonreuters.com)
Recent news on Harrow
See all newsHarrow, Inc. reports results for the quarter ended June 30 - Earnings Summary
Harrow Q2 revenue slightly beats estimates
Viatris raises annual profit forecast on branded drug strength
Brief: Harrow Re-Launches Verkazia® (Cyclosporine Ophthalmic Emulsion) 0.1% For Vernal Keratoconjunctivitis, Addressing Significant Unmet Need In Pediatric Eyecare
Harrow Q1 revenue misses analyst estimates